Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

Thu Jan 3, 2013 3:08pm EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130103:nBw036302a

NEW YORK--(Business Wire)--
Bristol-Myers Squibb Company (NYSE: BMY) will present at the 31st Annual J.P.
Morgan Healthcare Conference on Tuesday, January 8, 2013, in San Francisco.
Lamberto Andreotti, chief executive officer,will make a formal presentation
about the company at 9:30 a.m. PST (12:30 p.m. EST). 

Investors and the general public are invited to listen to a live webcast of the
presentation at http://investor.bms.com. Materials related to the presentation
will be available at the same website at the start of the live webcast. An
archived edition of the presentation will be available later that day. 

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or follow
us on Twitter at http://twitter.com/bmsnews.

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com

Copyright Business Wire 2013